SpliceBio
Marianna Di Scala has an extensive background in research and leadership roles within the biotechnology and scientific sectors. With experience ranging from postdoctoral work to project leadership positions, Marianna has worked in various prestigious organizations such as SpliceBio, VIVEbiotech, and CNIC. Marianna holds a Doctor of Philosophy degree in Biología celular y molecular from the University of Navarra, a Master's degree in Pharmaceutical Biotechnology, and a Bachelor's degree in Medical Biotechnology from Università degli Studi di Napoli Federico II.
This person is not in any teams
SpliceBio
Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.